Invention Grant
- Patent Title: Methods for improving cognitive function via modulation of quinone reductase 2
-
Application No.: US16173959Application Date: 2018-10-29
-
Publication No.: US10676747B2Publication Date: 2020-06-09
- Inventor: Kobi Rosenblum , Akiva Rappaport
- Applicant: Carmel-Haifa University Economic Corp. Ltd.
- Applicant Address: IL Haifa
- Assignee: CARMEL-HAIFA UNIVERSITY ECONOMIC CORP. LTD.
- Current Assignee: CARMEL-HAIFA UNIVERSITY ECONOMIC CORP. LTD.
- Current Assignee Address: IL Haifa
- Agency: Knobbe, Martens, Olson & Bear LLP
- Main IPC: C12N15/113
- IPC: C12N15/113 ; A61K31/7105 ; A61K31/713 ; A61K31/165 ; A61K31/404 ; A61K31/4045 ; A61K31/4375 ; A61K31/455 ; A61K31/7064 ; A61K31/255
Abstract:
An active agent capable of reducing quinone reductase 2 activity is for use in improvement of cognition in a subject. Such an active agent can be a nucleic acid molecule that reduces the gene expression level of quinone reductase 2 or an inhibitor of quinone reductase 2 activity. A pharmaceutical composition can contain the active agent or a vector containing the active agent.
Public/Granted literature
- US20190119684A1 METHODS FOR IMPROVING COGNITIVE FUNCTION VIA MODULATION OF QUINONE REDUCTASE 2 Public/Granted day:2019-04-25
Information query
IPC分类:
